Similar Search Results

Do people have a bias for low-deductible insurance?

Kunreuther, Howard; Pauly, Mark V. - 2020

Persistent link: https://www.econbiz.de/10012222006

Dynamic insurance decision-making for rare events : the role of emotions

Kunreuther, Howard; Pauly, Mark V. - In: The Geneva papers on risk and insurance - issues and … 43 (2018) 2, pp. 335-355

Persistent link: https://www.econbiz.de/10012256168

Behavioral economics of multiperiod insurance purchasing behavior : the role of emotions

Kunreuther, Howard; Pauly, Mark V. - 2018

Persistent link: https://www.econbiz.de/10012016318

Responses to Losses in High Deductible Health Insurance : Persistence, Emotions, and Rationality

Pauly, Mark V.; Kunreuther, Howard - 2017

Persistent link: https://www.econbiz.de/10011810757

Does high cost-sharing slow the long-term growth rate of health spending? : evidence from the states

Frean, Molly; Pauly, Mark V. - 2018

Persistent link: https://www.econbiz.de/10011926515

The price of responsibility : the impact of health reform on non-poor uninsureds

Pauly, Mark V.; Leive, Adam; Harrington, Scott E. - 2015

Persistent link: https://www.econbiz.de/10011350549

Social impact bonds : new product or new package?

Pauly, Mark V.; Swanson, Ashley - In: The journal of law, economics, & organization 33 (2017) 4, pp. 718-760

Persistent link: https://www.econbiz.de/10011795784

Medical employment growth, unemployment, and the opportunity cost of health care

Pauly, Mark V.; Nimgaonkar, Vivek - In: International journal of health economics and management 16 (2016) 4, pp. 387-396

Persistent link: https://www.econbiz.de/10011776451

Costs and benefits of branded drugs : insights from cost-effectiveness research

Frech, Henry Edward; Pauly, Mark V.; Comanor, William S.; … - In: Journal of benefit-cost analysis : JBCA 13 (2022) 2, pp. 166-181

The relationship between costs and health benefits of branded pharmaceuticals remains controversial. This paper examines the incremental costs incurred for incremental health benefits gained from the largest available sample of cost-effectiveness studies of branded drugs in the USA, the...

Persistent link: https://www.econbiz.de/10013366987

Financing long-term care : what should be the government's role?

Pauly, Mark V.; Zweifel, Peter - 1996

Persistent link: https://www.econbiz.de/10013538438